This paper studies the different kinds of business models within the biotech cluster in Italy. A balance sheet analysis of 88 biotech firms shows the main differences among them: according to the characteristics of the business model, some indexes are better than others in describing the structural characteristics of the biotech firms. As the research firms have a weak financial structure, a public policy supporting access to finance for high-tech firms is requested.
Nel rispetto della Direttiva 2009/136/CE, ti informiamo che il nostro sito utilizza i cookies. Se continui a navigare sul sito, accetti espressamente il loro utilizzo.